Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

559 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Re: Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 Guideline.
Gandaglia G, Briganti A, Chiti A, Cozzarini C, Montorsi F. Gandaglia G, et al. Eur Urol Oncol. 2023 May 12:S2588-9311(23)00077-9. doi: 10.1016/j.euo.2023.04.001. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37183078 No abstract available.
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.
Surcel C, Mirvald C, Tsaur I, Borgmann H, Heidegger I, Labanaris AP, Sinescu I, Tilki D, Ploussard G, Briganti A, Montorsi F, Mathieu R, Valerio M, Jinga V, Badescu D, Radavoi D, van den Bergh RCN, Gandaglia G, Kretschmer A; as part of the EAU-YAU PCa Working Party. Surcel C, et al. Among authors: gandaglia g. World J Urol. 2021 Jul;39(7):2483-2490. doi: 10.1007/s00345-020-03493-5. Epub 2020 Nov 1. World J Urol. 2021. PMID: 33135127
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology.
Ratti MM, Gandaglia G, Sisca ES, Derevianko A, Alleva E, Beyer K, Moss C, Barletta F, Scuderi S, Omar MI, MacLennan S, Williamson PR, Zong J, MacLennan SJ, Mottet N, Cornford P, Aiyegbusi OL, Van Hemelrijck M, N'Dow J, Briganti A. Ratti MM, et al. Among authors: gandaglia g. Cancers (Basel). 2022 Oct 19;14(20):5120. doi: 10.3390/cancers14205120. Cancers (Basel). 2022. PMID: 36291905 Free PMC article. Review.
Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128-36: Let's Not Go Back in Time! What Have We Learned in the Treatment of Localized Prostate Cancer? Applicability of the ENACT Randomized Clinical Trial in Clinical Practice.
Gómez Rivas J, Gandaglia G, Montorsi F. Gómez Rivas J, et al. Among authors: gandaglia g. Eur Urol Open Sci. 2022 Nov 14;46:135-136. doi: 10.1016/j.euros.2022.09.022. eCollection 2022 Dec. Eur Urol Open Sci. 2022. PMID: 36405303 Free PMC article. No abstract available.
Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis.
Barletta F, Tappero S, Panunzio A, Incesu RB, Cano Garcia C, Piccinelli ML, Tian Z, Gandaglia G, Moschini M, Terrone C, Antonelli A, Tilki D, Chun FKH, De Cobelli O, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Barletta F, et al. Among authors: gandaglia g. Urol Oncol. 2023 Mar;41(3):147.e1-147.e6. doi: 10.1016/j.urolonc.2022.10.027. Epub 2022 Nov 22. Urol Oncol. 2023. PMID: 36428165
Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions.
Martini A, Touzani A, Mazzone E, Roumiguié M, Marra G, Valerio M, Beauval JB, Campi R, Minervini A, van den Berg RCN, Soeterik TFW, Zhuang J, Guo H, Gontero P, Montorsi F, Briganti A, Gandaglia G, Ploussard G; Young Academic Urologists Working Group on Prostate Cancer of the European Association of Urology. Martini A, et al. Among authors: gandaglia g. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):806. doi: 10.1038/s41391-022-00637-z. Prostate Cancer Prostatic Dis. 2023. PMID: 36670304 No abstract available.
Re: Bo Dai, Sheng Zhang, Fan-Ning Wan, et al. Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer : A Phase 2 Randomized Controlled Trial. Eur Urol Oncol 2022;5:519-25.
Montorsi F, Barletta F, Gandaglia G. Montorsi F, et al. Among authors: gandaglia g. Eur Urol Oncol. 2023 Aug;6(4):451. doi: 10.1016/j.euo.2023.01.006. Epub 2023 Jan 25. Eur Urol Oncol. 2023. PMID: 36707322 Clinical Trial. No abstract available.
Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium.
Omar MI, MacLennan S, Ribal MJ, Roobol MJ, Dimitropoulos K, van den Broeck T, MacLennan SJ, Axelsson SE, Gandaglia G, Willemse PP, Mastris K, Ransohoff JB, Devecseri Z, Abbott T, De Meulder B, Bjartell A, Asiimwe A, N'Dow J; PIONEER Consortium. Omar MI, et al. Among authors: gandaglia g. Nat Rev Urol. 2023 Aug;20(8):494-501. doi: 10.1038/s41585-023-00748-9. Epub 2023 Apr 3. Nat Rev Urol. 2023. PMID: 37012441 Review.
559 results